| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9378(90)90376-I |
| P8608 | Fatcat ID | release_x3piz6k455ejjk6a2w7dlz6gkq |
| P698 | PubMed publication ID | 2309811 |
| P50 | author | Baha Sibai | Q100559638 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HELLP syndrome | Q1563513 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 311-316 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? | |
| P478 | volume | 162 |
| Q33661175 | A Case Report of the Nutrition Support for a Patient with HELLP Syndrome |
| Q72107566 | A case of HELLP syndrome at 23 weeks' gestation |
| Q38444723 | A clinicohistopathologic comparison between HELLP syndrome and severe preeclampsia |
| Q97645138 | Abdominal compartment syndrome complicated by preeclampsia and partial HELLP syndrome in a 45-year-old woman: A case report |
| Q35084804 | Abdominal pain during pregnancy. |
| Q30440028 | Abstraction-based temporal data retrieval for a Clinical Data Repository. |
| Q35228463 | Acute liver failure in pregnancy: Challenges and management |
| Q45049655 | Acute renal failure during eclampsia: incidence risks factors and outcome in intensive care unit |
| Q33416148 | Acute subdural haemorrhage in the postpartum period as a rare manifestation of possible HELLP (haemolysis, elevated liver enzymes, and low-platelet count) syndrome: a case report |
| Q46331247 | An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome? |
| Q51302521 | An unusual cause of postpartum collapse or a red herring? |
| Q35040099 | Anemia and the liver. Hepatobiliary manifestations of anemia |
| Q80473988 | Anesthetic management of preeclampsia/eclampsia |
| Q41986259 | Antepartum intracranial hemorrhage due to unrecognized unilateral moyamoya disease: a case report |
| Q59413161 | Anticorps antiphospholipides au cours du syndrome HELLP : étude clinique et biologique à partir de 68 patientes |
| Q73356668 | Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene |
| Q36930401 | CHOROIDAL MORPHOLOGY IN A PATIENT WITH HELLP SYNDROME. |
| Q34734412 | COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome. |
| Q36501451 | Caring for pregnant and postnatal women in intensive care: what do we know? |
| Q33377704 | Characteristic laboratory changes in pregnancies complicated by HELLP syndrome |
| Q46347264 | Clinical and biological characteristics of a group of 54 pregnant women with HELLP syndrome |
| Q43991934 | Clinical trial of expectant management of severe preeclampsia that develops at <32 weeks' gestation at a Japanese perinatal center |
| Q34393266 | Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. |
| Q37769887 | Coagulation abnormalities and obstetric anaesthesia |
| Q45985749 | Comparative analysis of maternal-fetal interface in preeclampsia and preterm labor. |
| Q33400357 | Comparison of maternal and neonatal outcomes in women with HELLP syndrome and women with severe preeclampsia without HELLP syndrome |
| Q73234919 | Corticosteroid therapy for conservative management in marginally-viable pregnancy complicated by HELLP syndrome |
| Q41987175 | Critical care management of obstetric emergencies |
| Q48217985 | Critical updates in the 7th edition of the American Society for Apheresis guidelines. |
| Q46859223 | Decreased hepatic perfusion in patients with HELLP syndrome |
| Q55223576 | Dengue fever during pregnancy. |
| Q87639934 | Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome |
| Q74256302 | Dexamethasone in the post-partum treatment of HELLP syndrome |
| Q33329194 | Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity |
| Q93216187 | Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome |
| Q74695886 | Effects of postpartum corticosteroids in patients with HELLP syndrome |
| Q48611828 | Extensive reversible brain magnetic resonance lesions in a patient with HELLP syndrome |
| Q38636657 | Factors contributing to adverse maternal outcomes in patients with HELLP syndrome |
| Q46341080 | Follow-up analysis of pregnancies complicated by HELLP syndrome |
| Q33766563 | Genetic aspects of preeclampsia and the HELLP syndrome. |
| Q72336105 | Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and HELLP syndrome |
| Q73811367 | HELLP (hemolysis, elevated liver enzymes, and low platelets) needs help |
| Q37277765 | HELLP Syndrome : Report of Two Cases |
| Q37718821 | HELLP Syndrome Complicated by Subcapsular Hematoma of Liver: A Case Report and Review of the Literature |
| Q71450952 | HELLP syndrome after the improvement of coagulation and fibrinolysis parameters in severe preeclampsia |
| Q72548858 | HELLP syndrome and coagulopathies of pregnancy |
| Q46433968 | HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone |
| Q37704164 | HELLP syndrome preceded by intrahepatic cholestasis of pregnancy: one serious itch |
| Q88149772 | HELLP syndrome: a diagnostic conundrum with severe complications |
| Q33681889 | HELLP syndrome: mechanisms and management |
| Q35885406 | HELLP syndrome: report of 61 cases and literature review |
| Q46334171 | HELLP syndrome: the experience at Ile-Ife, Nigeria |
| Q38105118 | HELLP syndrome: understanding and management of a pregnancy-specific disease. |
| Q44133182 | Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management |
| Q33496080 | Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). |
| Q33349453 | Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. |
| Q36811203 | Hepatic rupture after cesarean section in a patient with HELLP syndrome: a case report and review of the literature. |
| Q50588292 | History of abortion and perinatal outcomes associated with preeclampsia in nulliparous Japanese women. |
| Q35764966 | Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia |
| Q40907827 | Hypertension and pregnancy: impact of the Working Group report. |
| Q40779892 | Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. |
| Q34025660 | Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome |
| Q73675281 | Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units |
| Q50594437 | Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. |
| Q33387170 | Immune thrombocytopenia in pregnancy |
| Q42017064 | Intensive Care Unit issues in eclampsia and HELLP syndrome |
| Q36750761 | Intensive care management of the HELLP syndrome |
| Q89584589 | Intracerebral Hemorrhage in Women: A Review with Special Attention to Pregnancy and the Post-Partum Period |
| Q47857696 | Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? |
| Q78168562 | Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome |
| Q71525034 | Liver disease in pregnancy |
| Q36633689 | Liver infarction in a woman with systemic lupus erythematosus and secondary anti-phospholipid and HELLP syndrome. |
| Q72066181 | Lupus Anticoagulant and HELLP Syndrome Complicated by Placental Abruption, Hepatic, Dermal and Adrenal Infarction |
| Q34224924 | Management and monitoring of severe preeclampsia |
| Q36890355 | Management of Preeclampsia |
| Q36058275 | Management of Spontaneous Hepatic Rupture on Top of HELLP Syndrome: Case Report and Review of the Literature |
| Q33333589 | Management of idiopathic thrombocytopenic purpura in pregnancy |
| Q73375667 | Marker for liver damage in neonates born to mothers with HELLP syndrome |
| Q38765116 | Maternal and neonatal outcomes in women with severe early onset pre-eclampsia before 26 weeks of gestation, a case series |
| Q46358525 | Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome |
| Q46316588 | Maternal and perinatal outcomes of eclampsia with and without HELLP syndrome in a teaching hospital in western Turkey |
| Q46355973 | Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome |
| Q46354706 | Maternal outcome following temporizing management of the (H)ELLP syndrome |
| Q46341335 | Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital |
| Q44060400 | Maternal outcomes according to mode of delivery in women with severe preeclampsia: a cohort study |
| Q44227596 | Measurement of plasma glutathione S-transferase in hepatocellular damage in pre-eclampsia |
| Q44574174 | Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome |
| Q43852447 | Neutrophil oxygen radical production in pre-eclampsia with HELLP syndrome |
| Q92376908 | Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Complete Blood Count Components in the First Trimester Do Not Predict HELLP Syndrome |
| Q64889381 | Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Routine Complete Blood Count Components in HELLP Syndrome: A Matched Case Control Study. |
| Q26746049 | No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All |
| Q51897857 | One-year infant outcome in women with early-onset hypertensive disorders of pregnancy. |
| Q44729626 | Outcome of pregnancies with HELLP syndrome complicated by acute renal failure (1989-1999). |
| Q30441553 | PROTEMPA: a method for specifying and identifying temporal sequences in retrospective data for patient selection |
| Q46317231 | Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes |
| Q35574183 | Pathophysiology of pre-eclampsia: Update on the role of nitric oxide |
| Q91874565 | Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study |
| Q30573957 | Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission |
| Q44367745 | Perinatal outcome with HELLP/partial HELLP complicating hypertensive disorders of pregnancy. An Indian rural experience |
| Q33683910 | Peripartum hemorrhage |
| Q36006201 | Pheochromocytoma Presenting as Partial HELLP Syndrome |
| Q51926830 | Physical well-being in women with a history of severe preeclampsia. |
| Q41452017 | Placental cytokines and the pathogenesis of preeclampsia |
| Q36512059 | Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia |
| Q34456410 | Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy |
| Q33400905 | Platelet counts and coagulation tests prior to neuraxial anesthesia in patients with preeclampsia: a retrospective analysis |
| Q38178725 | Post-partum recovery course in patients with gestational hypertension and pre-eclampsia |
| Q61837466 | Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): does delayed primary closure make a difference? |
| Q34214896 | Postpartum HELLP syndrome after a normotensive pregnancy |
| Q34756059 | Postpartum acute renal failure: a multicenter study of risk factors in patients admitted to ICU. |
| Q30435894 | Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications |
| Q43963039 | Postpartum thrombotic microangiopathic syndrome. |
| Q33587603 | Pre-eclampsia and the HELLP syndrome still cause maternal mortality in The Netherlands and other developed countries; can we reduce it? |
| Q45783012 | Prediction of recurrence of hypertensive disorders of pregnancy between 34 and 37 weeks of gestation: a retrospective cohort study |
| Q37611406 | Preeclampsia and eclampsia incidence in the eastern anatolia region of Turkey: the effects of high altitude |
| Q51238543 | Preeclampsia complicated by placental abruption, HELLP, coagulopathy and renal failure - further lessons. |
| Q37366512 | Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? |
| Q44874940 | Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases |
| Q36573070 | Preeclampsia: Diagnosis and management of the atypical presentation |
| Q67472241 | Pregnancy-Induced Hypertension: Understanding Severe Preeclampsia and the HELLP Syndrome |
| Q37078953 | Pregnancy-associated liver disorders |
| Q44014222 | Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome |
| Q46334288 | Psychological treatment of women with psychological complaints after pre-eclampsia |
| Q36464790 | Racial disparity in placental pathology in the collaborative perinatal project |
| Q28195962 | Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère–Enfant study (Part 2) |
| Q46860417 | Relationship between thrombophilic disorders and type of severe early-onset hypertensive disorder of pregnancy |
| Q36058667 | Renal evaluation in women with preeclampsia |
| Q43929278 | Results of the pregnancies with HELLP syndrome |
| Q73937666 | Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group |
| Q61450132 | Risk factors for eclampsia in pregnant women with preeclampsia and positive neurosensory signs |
| Q50621578 | Risk factors for preeclampsia in Japanese twin pregnancies: comparison with those in singleton pregnancies. |
| Q47546316 | Role and mechanism of AT1-AA in the pathogenesis of HELLP syndrome |
| Q36407648 | Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation |
| Q37548260 | Severe early onset hemolysis, elevated liver enzyme, and low platelet-syndrome in 2 subsequent pregnancies: case report and review of the literature |
| Q44717981 | Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. |
| Q71745400 | Spontaneous rupture of the liver during pregnancy |
| Q39453429 | Spontaneous subcapsular hepatic hemorrhage associated with pregnancy: report of a case |
| Q34403656 | Surgical treatment of HELLP syndrome-associated liver rupture -- an update |
| Q34487118 | The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design |
| Q21261342 | The HELLP syndrome: clinical issues and management. A Review |
| Q46302659 | The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review |
| Q38664824 | The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study |
| Q33345766 | Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management |
| Q33359736 | Thrombocytopenia in the parturient |
| Q33342901 | Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion |
| Q33337048 | Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone |
| Q55003601 | Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. |
| Q36886075 | Upper abdominal pain in pregnancy may indicate pre-eclampsia |
| Q35750283 | Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome |
| Q55154816 | Wound haematoma: The first sign in a case of late postpartum HELLP syndrome. |
| Q98564696 | [HELLP syndrome: controversies and prognosis] |
| Q77225359 | [Hemolysis can conceal another hemolysis] |
| Q46353718 | [Maternal and perinatal morbidity and mortality associated with hellp syndrome] . |
| Q78658329 | [Pregnancy-related hypertension] |
Search more.